HCA Healthcare’s wholly owned subsidiary completed a $6,500,000,000 public offering of senior notes on November 5, 2026, guaranteed on a senior unsecured basis by HCA Healthcare.
HCA · HCA Healthcare, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
HCA Healthcare, Inc. announced that HCA Inc. proposes a senior unsecured notes offering. HCA Inc. elected to redeem all $1.200 billion of 4.500% senior notes due February 2027 on December 2, 2026, conditioned on receiving offering proceeds.
HCA Healthcare, Inc. reported third-quarter 2026 revenue of $19.849 billion, up 3.6%, while net income attributable to the company declined to $1.579 billion, or $7.27 per diluted share. Uninsured admissions rose 27.2%.
HCA Healthcare reported adjusted admissions growth of 3%, exchange admissions down approximately 19%, and an approximately $400 million adjusted EBITDA payer-mix headwind. It expects 2026 results in the upper half of guidance ranges and 2027 earnings consistent with 2026.
HCA Healthcare reported third-quarter revenues of $19.849 billion and Adjusted EBITDA of $3.918 billion, expects full-year operating results in the upper half of 2026 guidance, and declared a quarterly dividend of $0.78 per share.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Oct 27, 2026TL;DR. Third-quarter revenue, adjusted EPS, adjusted EBITDA, admissions, emergency-room visits, pricing, cost performance and operating cash flow improved; management expects 2026 results in the upper half of guidance, a $600 million to $800 million incremental Medicaid supplemental-payment benefit, and continued capital returns. Net income and adjusted EBITDA margin declined, payer mix created a $400 million quarterly headwind, surgical volumes fell, and preliminary 2027 earnings are expected to be generally consistent with 2026 as Medicaid supplemental benefits decline by $550 million to $650 million.
- + Cost per equivalent admission excluding Medicaid supplemental payments was essentially flat year over year and improved 40 basis points sequentially.
- + Management expects full-year 2026 operating results in the upper half of its previously issued guidance ranges.
- + The full-year 2026 incremental net benefit from Medicaid supplemental-payment programs is now expected to be $600 million to $800 million.
- − The payer-mix shift had an unfavorable impact of approximately $400 million in the third quarter, and the full-year adjusted EBITDA headwind is expected to be at or slightly above the upper end of prior estimates.
- − Same-facility inpatient surgeries declined 1.4% and outpatient surgeries declined 3.7% year over year.
- − The preliminary 2027 outlook includes $550 million to $650 million less Medicaid supplemental-payment net benefit, with earnings generally consistent with 2026.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HCA
this stock
HCA Healthcare, Inc.
|
$104.69B | +7.4% | +7.1% | 16.6 | 2.3% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$33.30B | +3.1% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.45B | +41.9% | +0.9% | 8.2 | 2.2% |
|
EHC
Encompass Health Corp
|
$13.53B | +29.9% | +10.5% | 21.5 | 3.7% |
|
FMS
Fresenius Medical Care AG
|
$11.26B | -8.9% | +5.9% | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 5, 2026
- This year
- 23
HCA Healthcare’s wholly owned subsidiary completed a $6,500,000,000 public offering of senior notes on November 5, 2026, guaranteed on a senior unsecured basis by HCA Healthcare.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HCA | -0.6% | +7.6% | +30.4% | +5.9% | +7.4% |
| SPY | -2.3% | -4.8% | -2.9% | -3.1% | +7.4% |
| vs SPY | +1.7% | +12.4% | +33.3% | +9.0% | -0.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.